Skip to content

The Use of Psychomotor Vigilance Testing in the Assessment of Pediatric Obstructive Sleep Apnea

The Use of Psychomotor Vigilance Testing in the Assessment of Pediatric Obstructive Sleep Apnea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01276860
Acronym
PVT
Enrollment
7
Registered
2011-01-13
Start date
2010-05-31
Completion date
2011-09-30
Last updated
2021-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Obstructive Sleep Apnea

Keywords

Obstructive Sleep Apnea, Pediatric Obstructive Sleep Apnea, OSA, PVT, Psychomotor Vigilance Testing, Psychomotor Vigilance Task

Brief summary

Obstructive sleep apnea results in decreased attentiveness and response times in patients. The objective of this study is to quantify these consequences in pediatric OSA patients using an already established tool for examining the results of sleep deprivation and fragmentation: psychomotor vigilance testing. PVT has been used in children, but has not been studied in pediatric OSA patients. This study aims to employ PVT along the normal course of diagnosis and treatment of pediatric OSA patients in our clinical practice at Arkansas Children's Hospital. The investigators hypothesize that pediatric OSA patients will exhibit decreased PVT scoring when compared to children without OSA, and that PVT can be used to diagnose and monitor treatment outcomes in these patients.

Interventions

DEVICEPsychomotor Vigilance Testing

The purpose of this study is to examine the use of psychomotor vigilance testing (PVT) as a tool in the diagnosis and prediction of pediatric obstructive sleep apnea. PVT simply involves responding to a light by pressing a button on a small handheld device. It is a simple measure of reaction time.

Sponsors

Arkansas Children's Hospital Research Institute
CollaboratorOTHER
University of Arkansas
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy pediatric patients ages 6-18 years old * with symptoms of OSA (snoring, pauses in sleep breathing, restless sleep, frequent arousals, excellive daytime sleepiness, morning headaches) * with physical exam findings consistent with adenotonsillar hypertrophy * those identified as good candidates for adenotonsillectomy * who are to undergo a polysomnogram as part of their preoperative work-up

Exclusion criteria

* History of attention deficit disorder, developmental delay, or mental retardation * Children taking any neurotropic medications (including antiepileptics, antidepressives, and stimulants) * Children previously treated for OSA (surgically or medically) * Children with significant comorbidities including other sleep-related disorders

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Achieved Criteria of Obstructive Sleep Apnea in the PVT Assessment10-20 minutes each session, 3 sessions totalSubjects with obstructive sleep apnea will be asked to participate in 3 sessions. Your child will be asked to complete some noninvasive tests at each session. These tests consist of Psychomotor Vigilance Task testing. A Psychomotor Vigilance Task (PVT) will measure your level of alertness and attentiveness. The PVT involves pressing a button after hearing a specific tone or seeing a flashing light. This test takes approximately 10 minutes to complete. The PVT testing will be done at the first clinic visit, then before any treatments, and finally after treatments have taken place. Outcome Measure is full completion of the PVT testing.

Secondary

MeasureTime frameDescription
Number of Participants Who Achieved Criteria of No Sleep Complaints in the PVT Assessment10-20 minute session, 1 sessionSubjects in the control group without clinical signs and symptoms of sleep apnea will only undergo PVT for one session. Your child will be asked to complete some noninvasive tests at this session. These tests consist of Psychomotor Vigilance Task testing. A Psychomotor Vigilance Task (PVT) will measure your level of alertness and attentiveness. The PVT involves pressing a button after hearing a specific tone or seeing a flashing light. This test takes approximately 10 minutes to complete. Outcome Measure is full completion of the PVT testing.

Countries

United States

Participant flow

Participants by arm

ArmCount
Treatment Group
PVT subjects with sleep complaints.Control subjects will be asked to participate in one session. Treatment subjects will be asked to participate in 3 sessions.
5
Control Group
PVT subjects without sleep complaints.Control subjects will be asked to participate in one session. Treatment subjects will be asked to participate in 3 sessions.
2
Total7

Baseline characteristics

CharacteristicTreatment GroupControl GroupTotal
Age, Customized
6-18 years
5 Participants2 Participants7 Participants
Region of Enrollment
United States
5 participants2 participants7 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
5 Participants2 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 2
other
Total, other adverse events
0 / 50 / 2
serious
Total, serious adverse events
0 / 50 / 2

Outcome results

Primary

Number of Participants Who Achieved Criteria of Obstructive Sleep Apnea in the PVT Assessment

Subjects with obstructive sleep apnea will be asked to participate in 3 sessions. Your child will be asked to complete some noninvasive tests at each session. These tests consist of Psychomotor Vigilance Task testing. A Psychomotor Vigilance Task (PVT) will measure your level of alertness and attentiveness. The PVT involves pressing a button after hearing a specific tone or seeing a flashing light. This test takes approximately 10 minutes to complete. The PVT testing will be done at the first clinic visit, then before any treatments, and finally after treatments have taken place. Outcome Measure is full completion of the PVT testing.

Time frame: 10-20 minutes each session, 3 sessions total

Population: The analysis of each participant is based on the timing between hearing a specific tone or seeing a flashing light and the pressing of the button to record the alertness and attentiveness. Finalized analysis is not completed as the study was ended early and data not analyzed to compare groups.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Treatment GroupNumber of Participants Who Achieved Criteria of Obstructive Sleep Apnea in the PVT Assessment5 Participants
Control GroupNumber of Participants Who Achieved Criteria of Obstructive Sleep Apnea in the PVT Assessment2 Participants
Secondary

Number of Participants Who Achieved Criteria of No Sleep Complaints in the PVT Assessment

Subjects in the control group without clinical signs and symptoms of sleep apnea will only undergo PVT for one session. Your child will be asked to complete some noninvasive tests at this session. These tests consist of Psychomotor Vigilance Task testing. A Psychomotor Vigilance Task (PVT) will measure your level of alertness and attentiveness. The PVT involves pressing a button after hearing a specific tone or seeing a flashing light. This test takes approximately 10 minutes to complete. Outcome Measure is full completion of the PVT testing.

Time frame: 10-20 minute session, 1 session

Population: The analysis of each participant is based on the timing between hearing a specific tone or seeing a flashing light and the pressing of the button to record the alertness and attentiveness. Finalized analysis is not completed as the study was ended early and data not analyzed to compare groups.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Treatment GroupNumber of Participants Who Achieved Criteria of No Sleep Complaints in the PVT Assessment5 Participants
Control GroupNumber of Participants Who Achieved Criteria of No Sleep Complaints in the PVT Assessment2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026